Etizolam is a specific antagonist at PAFR. It inhibits PAF-induced platelet aggregation by inhibiting PAF binding for the receptors Situated around the surface of platelets having an IC50 of 22nM five. Cureus delivers https://elodiebvvv968299.pointblog.net/k2-research-can-be-fun-for-anyone-72027377